Remix Therapeutics

Remix Therapeutics

Edit info

  • Founded: 2019
  • Location: Cambridge, MA
  • Employee range: 50 - 200
  • Clinical stage: RD
  • Therapy area: Oncology
  • Drug types: ONC, NEU, GEN
  • Lead product: Undisclosed
  • Funding: $70M B May 2022; $81M A Dec 2020
  • Investors: Surveyor, Foresite Capital, Atlas Venture, The Column Group, Arch Venture Partners, Alexandria Venture Investments, Casdin Capital


remixtx.com

linkedin.com

job board


Business:

Small molecule therapies designed to reprogram RNA processing

Drug notes:

Additional undisclosed programs RD CNS diseases, genetic disorders, undisclosed

About:

Remix Therapeutics is developing small molecule therapeutics to alter the expression of mRNA and proteins driving disease. RNA processing is a tightly regulated process that impacts the abundance of proteins synthesized. Using their REMaster drug discovery platform, Remix is identifying druggable target sites and active chemical matter to advance novel therapies that can alter RNA expression and restore functional levels. The proprietary platform combines data science and bioinformatics to identify modifiable sites with multiplexed high-throughput screening technologies that uses their chemical library enriched for compounds that can interact with RNA processing machinery. Remix is currently building a pipeline of RNA processing modulators across oncology and neurodegeneration.

Remix Therapeutics
Research Associate Contractor, Biochemistry/Biophy...
Watertown, MA|16 days ago
Apply
Remix Therapeutics
Senior Research Associate Contractor, Hit Validati...
Watertown, MA|37 days ago
Remix Therapeutics
Research Associate Contractor, Hit Validation and ...
Watertown, MA|66 days ago
Remix Therapeutics
Research Associate Contractor, Biology
Watertown, MA|86 days ago
Remix Therapeutics
General Career Inquiry
Watertown, MA|100+ days ago


© 2025 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com